Hospital pharmacists boost lifesaving vaccine rates in vulnerable patients

NCT ID NCT05060146

First seen Jan 05, 2026 · Last updated May 11, 2026 · Updated 15 times

Summary

This study tested whether a pharmacist-led program could increase pneumococcal vaccination rates in patients at high risk for serious infections. Over 600 hospitalized adults with conditions like chronic disease or weakened immune systems took part. The pharmacist reviewed their medications and encouraged vaccination before discharge. The goal was to see if this extra support leads to more people getting the recommended two vaccine doses.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STREPTOCOCCUS PNEUMONIAE INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • CH Alès Cévennes

    Alès, France

  • CH Comminges Pyrénées

    Saint-Gaudens, France

  • CH de Bagnols sur Cèze

    Bagnols-sur-Cèze, France

  • CH de Montauban

    Montauban, France

  • CH de Perpignan

    Perpignan, France

  • CH du Bassin de Thau

    Sète, France

  • CHU de Montpellier

    Montpellier, France

  • CHU de Nimes

    Nîmes, France

  • CHU de Toulouse

    Toulouse, France

Conditions

Explore the condition pages connected to this study.